Delivery Order SPE2DB20D2104-SPE2DB25FMMDQ

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $31,327.60 and a period of performance through March 24, 2025. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $1,474.77 and runs through September 11, 2024. The contract is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $11,862.03 and a completion date of January 2, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $3,342.64 and an ultimate completion date of February 20, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $49,878.88 and an ultimate completion date of March 3, 2025. The contract is a Firm Fixed Price type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $2,368.67 and is structured as a firm fixed-price delivery order, with a period of performance ending on July 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $46,495.69 and runs through September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $23,524.62 and a period of performance through May 9, 2023. It is a firm fixed-price contract, classified as a delivery order with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $16,647.60 and a period of performance through March 19, 2025. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $15,895.84. The contract is a firm fixed-price delivery order that runs through March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMMDQ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $1,961.48 and runs through March 31, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/27/25, 12:10 PM